Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cardiac failure chronic+1

Recruiting

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose

Contact Research Centre

Migraine

Recruiting

Investigational

Study on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17

Investigational

Portugal

Participants:0–17 years
Substances:Atogepant

Contact Research Centre

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Recruiting

Registered drugNo placebo

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Migraine

Recruiting

Registered drug

Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

Registered drug

Portugal

Participants:0–17 years
Substances:Eptinezumab

Contact Research Centre

Clostridium difficile infection

Recruiting

Investigational

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Contact Research Centre

Migraine

Recruiting

Registered drugNo placebo

Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

Registered drugNo placebo

Portugal

Participants:0–17 years
Substances:Eptinezumab

Contact Research Centre

Spinal cord injury

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Eletriptan

Contact Research Centre

Adenocarcinoma of colon

Recruiting

Registered drugNo placebo

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Pulmonary arterial hypertension

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Treprostinil

Contact Research Centre

Migraine+2

Recruiting

InvestigationalNo placebo

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo

Portugal

Participants:0–17 years
Substances:Atogepant

Contact Research Centre

Juvenile idiopathic arthritis

Recruiting

Registered drugNo placebo

Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

Registered drugNo placebo

Portugal

Participants:0–17 years · 18–64 years
Substances:Abatacept

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Registered drug

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Registered drug

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Find therapies in clinical trials near you – page 3

96 trials match your criteria

Cardiac failure chronic+1

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Migraine

Study on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Migraine

Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

Clostridium difficile infection

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Migraine

Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

Spinal cord injury

Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

Adenocarcinoma of colon

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Pulmonary arterial hypertension

Study on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)

Migraine+2

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

Juvenile idiopathic arthritis

Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

Dermatitis atopic

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.